Data / Form D filings / Sernova Biotherapeutics Inc.
Sernova Biotherapeutics Inc.: Form D filing
Sernova Biotherapeutics Inc., a biotechnology company in Mississauga, Ontario, Canada, filed a Form D with the SEC in 2026. The latest, on February 5, 2026, reports $344,514 sold of a $843,153 offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- PO 29592 RPO Central Parkway, Mississauga, Ontario, Canada, L5A4H
- Phone
- (416) 457-4670
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Ontario, Canada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2102368
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 5, 2026 | New notice | $843,153 | $344,514 | $498,639 | 3 | Oct 31, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| James Parsons | Executive Officer | |
| Jonathan Rigby | Executive Officer, Director | Chief Executive Officer and Director |
| Bernd Muehlenweg | Director | |
| John Brooks | Director | |
| David Paterson | Director | |
| Steven Sangha | Director | |
| Tanya Lewis | Director | |
| David Burke | Executive Officer | Vice President, Investor Relations |
| Marylyn Rigby | Executive Officer | Chief Communications Officer |
Every Form D from the week of Feb 2, 2026 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Sernova Biotherapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.